https://www.selleckchem.com/pr....oducts/anlotinib-al3
Treatment effect estimation must account for observed confounding, in which factors affect treatment assignment and outcomes simultaneously. Ignoring observed confounding risks concluding that a helpful treatment is not beneficial or that a treatment is safe when actually harmful. Propensity score matching or weighting adjusts for observed confounding, but the best way to use propensity scores for multiple treatments is unknown. It is unclear when choice of a different weighting or matching strategy leads to divergent inference
Curtir
Comentario
Compartilhar
